Binay Kumar Shah Selected Research

Binay Kumar Shah Research Topics

3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2016 - 12/2014
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2015 - 09/2014
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2016 - 06/2015
2	Neoplasms (Cancer) 07/2015 - 12/2014
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2015
1	Blindness (Hysterical Blindness) 11/2014
1	Heart Failure 10/2014
1	Anaphylaxis (Anaphylactic Shock) 05/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2011
1	Thrombocytopenia (Thrombopenia) 01/2011
1	Anemia 02/2002

2	Imatinib Mesylate (Gleevec)FDA Link 04/2016 - 12/2014
2	Tyrosine Kinase InhibitorsIBA 01/2015 - 12/2014
2	IronIBA 01/2011 - 02/2002
1	Temozolomide (Temodar)FDA LinkGeneric 01/2016
1	Sorafenib (BAY 43-9006)FDA Link 01/2015
1	Vincristine (Oncovin)FDA LinkGeneric 11/2014
1	Bortezomib (Velcade)FDA Link 10/2014
1	Rituximab (Mabthera)FDA Link 09/2014
1	Pemetrexed (MTA)FDA Link 05/2013
1	abirateroneIBA 01/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2002